12:00 AM
 | 
Aug 05, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Plan B One-Step levonorgestrel tablet 1 regulatory update

FDA granted 3-year exclusivity for OTC contraceptive Plan B One-Step levonorgestrel from Teva. Exclusivity ends on April 30, 2016, 3 years after the date the agency approved an sNDA for emergency contraceptive...

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >